rs193922415

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_000377.3(WAS):​c.37C>G​(p.Arg13Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,098,151 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R13Q) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

2
5
10

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.548

Publications

0 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28934026).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASNM_000377.3 linkc.37C>G p.Arg13Gly missense_variant Exon 1 of 12 ENST00000376701.5 NP_000368.1 P42768A0A024QYX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASENST00000376701.5 linkc.37C>G p.Arg13Gly missense_variant Exon 1 of 12 1 NM_000377.3 ENSP00000365891.4 P42768

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1098151
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
363507
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26399
American (AMR)
AF:
0.00
AC:
0
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
842063
Other (OTH)
AF:
0.00
AC:
0
AN:
46095
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.022
T;T
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.52
T;T
M_CAP
Pathogenic
0.73
D
MetaRNN
Benign
0.29
T;T
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Benign
1.3
.;L
PhyloP100
0.55
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.47
Sift
Benign
0.038
D;D
Sift4G
Uncertain
0.033
D;T
Polyphen
0.0
.;B
Vest4
0.32
MutPred
0.30
Loss of methylation at R13 (P = 0.012);Loss of methylation at R13 (P = 0.012);
MVP
0.84
MPC
0.75
ClinPred
0.20
T
GERP RS
2.1
PromoterAI
-0.071
Neutral
Varity_R
0.18
gMVP
0.65
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922415; hg19: chrX-48542279; API